Product Reviews
Categories
- Alternative Medicine
- Cancer
- Acute Promyelocytic Leukemia
- Anal Cancer
- Bladder Cancer
- Breast cancer
- Colorectal cancer
- Endometrial Cancer
- Esophageal Cancer
- Gallbladder cancer
- Gastric Cancer
- Glioblastma
- Head and Neck Cancer
- Liver Cancer
- Lung Cancer
- Lymphoma
- Melanoma
- Nasopharyngeal Cancer
- Non-Hodgkin's Disease
- Ovarian Cancer
- Pancreatic Cancer
- Prostate cancer
- Renal Cancer
- Thyroid Cancer
- Cardiovascular disease
- Central Nervous System
- Constipation
- Diabetes
- Fatty Liver
- Irritable Bowel Syndrome
- Longevity
- Motherhood
- Obesity
- Others
- Psoriasis
- Respiratory Disease
- Rheumatoid Arthritis
Archives
Tag Archives: gemcitabine
Which is Best Chemotherapy Option for Advanced Bladder Cancer?
Transitional cell or urothelial carcinoma is the most common type of bladder cancer, accounting for more than 90% all bladder cancers. This type of cancer is sensitive to treatment with chemotherapeutic agents. This type of cancer is usually treated with … Continue reading
Posted in Bladder Cancer, Cancer
Tagged advanced bladder cancer, carboplatin, chemotherapy, Cisplatin, doxorubicin, gemcitabine, methotreaxate, MVAC, Transitional cell carcinoma, urothelial carcinoma, vinblastine
Comments Off on Which is Best Chemotherapy Option for Advanced Bladder Cancer?
First-Line Erlotinib Triples Progression-Free Survival in NSCLC in Chinese Population
First-line erlotinib (Tarceva) tripled the progression-free survival in advanced non–small cell lung carcinoma (NSCLC) patients who had endothelial growth factor receptor (EGFR)-activating mutation, according to the OPTIMAL study presented at the 35th European Society for Medical Oncology Congress. The study … Continue reading
Posted in Cancer, Lung Cancer, Non Small Cell Lung Cancer
Tagged carboplatin, endothelial growth factor receptor, erlotinib, gemcitabine, Gemzar, non–small cell lung carcinoma, NSCLC, OPTIMAL, progression-free, Survival, Tarceva
Comments Off on First-Line Erlotinib Triples Progression-Free Survival in NSCLC in Chinese Population
Pancreatic cancer – Causes, Prevention, Prognosis, Diagnosis and Latest Treatment
Prevalence Pancreatic cancer is the fourth most common cause of adult cancer death, accounting for an estimated 42,470 new cases and 35,240 deaths in USA for 2009. The high mortality rate is due to the high incidence of metastatic disease … Continue reading
Posted in Pancreatic Cancer
Tagged Avastin, bevacizumab, capecitabine, Causes, Diagnosis, Eloxatin, erlotinib, gemcitabine, Gemzar, oxaliplatin, Pancreatic Cancer, Prevention, Prognosis, Survival, Tarceva, Treatment, Xeloda
2 Comments
New Standard Treatment for Advanced Biliary Tract Cancer: Cisplatin Plus Gemcitabine
Good news for patients with advanced biliary tract cancer. Combination of cisplatin and gemcitabine (Gemzar) have been shown to be an effective treatment option for patients with locally advanced or metastatic biliary tract cancer. In developed nations, biliary tract cancer … Continue reading
Posted in Cancer, Gallbladder cancer
Tagged Biliary tract cancer, cholangiocarcinoma, Cisplatin, gallbladder cancer, gemcitabine, Gemzar, Survival
Comments Off on New Standard Treatment for Advanced Biliary Tract Cancer: Cisplatin Plus Gemcitabine
Alternative Treatment Options for Late Stage Lung Cancer Patients
Paclitaxel plus carboplatin(PC) is the current standard regimen for advanced or metastatic non-small-cell lung cancer (NSCLC) patients. However, paclitaxel is associated with serious toxicity such as peripheral neuropathy. A tria,l published in October version of the Annals of Oncology, was … Continue reading
Posted in Cancer, Lung Cancer
Tagged carboplatin, chemotherapy, gemcitabine, Lung Cancer, NSCLC, paclitaxel, Stage III, Stage IV, Survival
Comments Off on Alternative Treatment Options for Late Stage Lung Cancer Patients
